APA (7th ed.) Citation

Straube, A., Broessner, G., Gaul, C., Hamann, X., Hipp, J., Kraya, T., & Neeb, L. (2023). Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: A subgroup analysis of the Finesse Study. Journal of headache and pain, 24(1), 59-11. https://doi.org/10.1186/s10194-023-01593-2

Chicago Style (17th ed.) Citation

Straube, Andreas, Gregor Broessner, Charly Gaul, Xenia Hamann, Joachim Hipp, Torsten Kraya, and Lars Neeb. "Real-world Effectiveness of Fremanezumab in Patients with Migraine Switching From another MAb Targeting the CGRP Pathway: A Subgroup Analysis of the Finesse Study." Journal of Headache and Pain 24, no. 1 (2023): 59-11. https://doi.org/10.1186/s10194-023-01593-2.

MLA (9th ed.) Citation

Straube, Andreas, et al. "Real-world Effectiveness of Fremanezumab in Patients with Migraine Switching From another MAb Targeting the CGRP Pathway: A Subgroup Analysis of the Finesse Study." Journal of Headache and Pain, vol. 24, no. 1, 2023, pp. 59-11, https://doi.org/10.1186/s10194-023-01593-2.